Secure Drug Supply Chain Act of 2026

Sponsor: Ted Budd (Republican-NC)July 21, 2026

AI-generated ?

Report an error

Introduced

In Committee

Passed One Chamber

Passed Both Chambers

Signed into Law

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

FDA would get more power to stop dangerous imported drugs and track their ingredients.

This bill would give the Food and Drug Administration (FDA) new tools to prevent counterfeit, unapproved, or unsafe drugs from entering the United States. It focuses on drugs and ingredients from countries known for intellectual property theft or forced labor, and would require drug makers to share more details about where their ingredients come from.

What Would Change

Today, drug manufacturers report the country of origin for active pharmaceutical ingredients annually. This bill would change that to quarterly reporting for certain drugs. Eventually, this would apply to all drugs that use ingredients from China or other "foreign countries of concern." It would also give the FDA stronger and more specific powers to block, seize, and order the destruction of unsafe or illegally sourced drugs, including those made with forced labor. These powers are not explicitly detailed in current law.

Key Provisions

The FDA would block unsafe drugs and ingredients from entering the U.S., especially from certain foreign countries.
Drug manufacturers would also have to report the country of origin for key drug ingredients every three months, rather than annually, for certain drugs.
The FDA would ban drugs made in facilities known to use forced labor or violate U.S. sanctions.
The FDA could order the destruction of dangerous imported drugs without allowing them to be sent back.
Foreign drug facilities using forced labor would not be allowed to register with the FDA, and existing registrations would be canceled.
Making false statements about imported drugs or re-importing a drug that was previously refused would become prohibited acts.

View on Congress.gov

S 5043 · 119th Congress · July 21, 2026 · AI Summary by gemini-2.5-flash · 10/10

Secure Drug Supply Chain Act of 2026

What Would Change

Key Provisions

Lobbying Activity